Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by TheTruth1234on May 23, 2023 9:58pm
118 Views
Post# 35461209

RE:RE:RE:They told you what they were going to do...

RE:RE:RE:They told you what they were going to do...
Boomskid wrote: Garbage, poof. Denali's value was and remains dependent on TV, ETV and the therapeutics created with them.

If either Denali or Bioasis announced that they could successfully treat brain tumours, do you seriously think that the pharmaceutical industry industry and the markets would ignore that?

Would the market ignore the $7 billion in annual revenue that a BBB-penetrant version of Herceptin could bring in? 

Even your precious S&P Biotech ETF would sit up and howl at the moon over that!

What is your agenda, poof, to post nonsense like that? Are you working for anybody we should know about?

jd



"What is your agenda, poof, to post nonsense like that? Are you working for anybody we should know about"?

What is your agenda here Johnny boy?


Same agenda you had when you unloaded millions of shares and warrants onto unsuspecting Shareholders, in your previous Oil and Gas scam?


Did you do the same here?


Were you selling bioasis shares when you were telling people to buy?


Now you try to slam DC and his successful subscription newsletter service. Imagine that.



You, on the other hand are now bankrupt, and could never have a business model as successful as TW Research. 


Keep er' coming Johnny boy!



Still waiting for you to "bring the fight" over to your pathetic website, and "reveal everything " about me.



Oh, I forgot to ask, is your bankruptcy complete yet?





<< Previous
Bullboard Posts
Next >>